Aptevo Therapeutics Introduces New Adaptir™ Bispecific Antibody Candidate Intended for the Treatment of Solid Tumors

Ads

You May Also Like

Immunicum AB (publ) Announces Upcoming Investor Events in January

Press Release 22 January 2019 Immunicum AB (publ) Announces Upcoming Investor Events in January ...

DBV Technologies Announces Results from Phase II Study of Viaskin Milk in Milk-Allergic Patients

Press ReleaseMontrouge, France, February 26, 2018                                                                                                                                                                           DBV Technologies Announces Results from Phase ...